News About: Pharm. Industry
Family feud flares again over control of Dong-A Pharmaceutical
A family feud within Korea's largest pharmaceutical company is rekindling as its incumbent president delivered a petition, asking shareholders to withdraw support for all of the ousted Kang Moon-seok's five candidates...
Choong-wae to open call center
Choong-wae Pharm said on October 15 it will open its call center across the nation to offer support and basic information on its medicines, healthcare products and medical devices by staff in the center, free of charg...
Diamesco receives EU certification for mechanical insulin injectorDiamesco, a local insulin pump manufacturer, acquired an EU's CE certification on the world's first mechanical insulin injector Libero.
Libero is a scaled-down insulin pump ...
|
Patent Court to rule Sanofi-Aventis's Plavix Patent soon
The local patent court will affirm the validity and enforceability of Sanofi-Aventis's Plavix Patent on clopidogrel bisulfate early next month, according to the market sources.
Clopidogrel is the active ingredient ...
Pharmaceutical firms look to smoking cessation market
A growing number of local pharmaceutical companies are headed for domestic smokeless tobacco market in a bid to expand their business lines, although the market size is estimated at 15 billion won.
Samyang Corporat...
Prigrel may be reimbursable depending on ruling of Plavix's patent suit
The government plans to get Chong Kun Dang's Prigrel (clopidogrel resignate) reimbursed depending on the ruling of Patent Court over Plavix's patent suit, according to an official at the Ministry of Health and Welfare...
Dong-A signs big drug export deal
Local drug maker Dong-A Pharmaceutical announced on October 15 that Zydena, its new oral tablet for erectile dysfunction (ED) will be distributed in Russia under a supply and distribution agreement with a largest Russ...
Six drug makers in race for top post for anti-obesity market.
Six pharmaceutical firms for producing sibutramine are engaged in cutthroat competition to take the top place in Korea's anti-obesity market with more heated promotional activities following expiration of Abbott's Red...
Concerns on new diabetes medicine
Worries are raised about the safety of a new diabetes medicine Januvia (sitagliptin phosphate), a drug expected to be big sellers for MSD Korea. But it is unclear if the concerns are justified or just the result of a ...
Monthly reporting for drug supply stirs debate
The government's plan to strengthen the obligation of pharmaceutical wholesalers to report their drug supply on a monthly basis instead of on a quarterly basis has recently emerged as a thorny issue in the industry.
...
